INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01Kurtz George0B / 239S · 10 late239 trades$59.22M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08RJRubinstein Julie0B / 37S37 trades$6.25M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Form 4 transactions

67,560 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
5
SB
Sandler Alan B.Chief Development Officer
RVMDRevolution Medicines, Inc.
Option exercise · 10b5-1 plan
M$353K
6,000 sh
Sep 29, 2026
Page 278 of 1689
← PrevNext →
Oct 1, 2026
traded Sep 29, 2026
+2d
SEC Form 4

Evidence

5
SS
Sayad Pierre SargisChief Medical Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A—
168 sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC Form 4

Evidence

4
Huffman Steve LaddDirector, CEO & President, 10% Owner
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$359K
2,500 sh
Sep 29, 2026Oct 1, 2026
traded Sep 29, 2026
+2dSEC Form 4

Evidence

4
Huffman Steve LaddDirector, CEO & President, 10% Owner
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$772K
5,308 sh
Sep 29, 2026Oct 1, 2026
traded Sep 29, 2026
+2dSEC Form 4

Evidence

3
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$78K
7,500 sh
Sep 29, 2026Oct 1, 2026
traded Sep 29, 2026
+2dSEC Form 4

Evidence

2
BP
Brown Jameson PruittDirector, TREASURER, 10% Owner
NENNEW ENGLAND REALTY ASSOCIATES LIMITED PARTNERSHIP
Other acquisition or disposition · 10b5-1 plan
J$25K
15 sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC Form 4

Evidence

2
Huffman Steve LaddDirector, CEO & President, 10% Owner
RDDTReddit, Inc.
Option exercise · 10b5-1 plan
M$438K
17.3K sh
Sep 29, 2026Oct 1, 2026
traded Sep 29, 2026
+2dSEC Form 4

Evidence

2
BP
Brown Jameson PruittDirector, TREASURER, 10% Owner
NENNEW ENGLAND REALTY ASSOCIATES LIMITED PARTNERSHIP
Other acquisition or disposition · 10b5-1 plan
J$660
0 sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC Form 4

Evidence

1
Huffman Steve LaddDirector, CEO & President, 10% Owner
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$114K
776 sh
Sep 29, 2026Oct 1, 2026
traded Sep 29, 2026
+2dSEC Form 4

Evidence

0
Huffman Steve LaddDirector, CEO & President, 10% Owner
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$43K
300 sh
Sep 29, 2026Oct 1, 2026
traded Sep 29, 2026
+2dSEC Form 4

Evidence

0
HT
Hamilton Brian TDirector, President of CCBX
CCBCOASTAL FINANCIAL CORP
Tax withholding · 10b5-1 plan
F$9,195
233 sh
Oct 1, 2026Oct 1, 2026
traded Oct 1, 2026
+0dSEC Form 4

Evidence

0
WG
Whalen Thomas GerardDirector
HCSGHEALTHCARE SERVICES GROUP INC
Grant or award · 10b5-1 plan
A$2,515
123 sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC Form 4

Evidence

0
GK
Grant Laura KDirector
HCSGHEALTHCARE SERVICES GROUP INC
Grant or award · 10b5-1 plan
A$7,505
367 sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC Form 4

Evidence

0
SG
Schiller Derek GordonEVP, Business
BATRKAtlanta Braves Holdings, Inc.
Option exercise · 10b5-1 plan
M—
175.4K sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC Form 4

Evidence

0
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
7,500 sh
Sep 29, 2026Oct 1, 2026
traded Sep 29, 2026
+2dSEC Form 4

Evidence

0
SK
Simmons Kurt JRDirector
HCSGHEALTHCARE SERVICES GROUP INC
Grant or award · 10b5-1 plan
A$15K
734 sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC Form 4

Evidence

0
HJ
Heller Gregory JohnEVP, CLO & Secretary
BATRKAtlanta Braves Holdings, Inc.
Option exercise · 10b5-1 plan
M—
80.3K sh
Sep 29, 2026Oct 1, 2026
traded Sep 29, 2026
+2dSEC Form 4

Evidence

0
SB
Sandler Alan B.Chief Development Officer
RVMDRevolution Medicines, Inc.
Option exercise · 10b5-1 plan
M—
6,000 sh
Sep 29, 2026Oct 1, 2026
traded Sep 29, 2026
+2dSEC Form 4

Evidence

0
Huffman Steve LaddDirector, CEO & President, 10% Owner
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$48K
324 sh
Sep 29, 2026Oct 1, 2026
traded Sep 29, 2026
+2dSEC Form 4

Evidence

0
Huffman Steve LaddDirector, CEO & President, 10% Owner
RDDTReddit, Inc.
Option exercise · 10b5-1 plan
M—
17.3K sh
Sep 29, 2026Oct 1, 2026
traded Sep 29, 2026
+2dSEC Form 4

Evidence

51
HK
Hartt Steven KnutConsultant of Sub Advisor
PMPEXPrimark Meketa Private Equity Investments Fund
Open-market purchase
BUY$10,000
573 sh
Sep 28, 2026Sep 30, 2026
traded Sep 28, 2026
+2dSEC Form 4

Evidence

51
SI
Samson Ethan IsaacDirector of Sub Advisor
PMPEXPrimark Meketa Private Equity Investments Fund
Open-market purchase
BUY$14K
831 sh
Sep 28, 2026Sep 30, 2026
traded Sep 28, 2026
+2dSEC Form 4

Evidence

51
KR
Kamfar RaminDirector
BPREBluerock Private Real Estate Fund
Open-market purchase
BUY$1.70M
135.7K sh
Sep 28, 2026Sep 30, 2026
traded Sep 28, 2026
+2dSEC Form 4

Evidence

50
WS
Woolley Peter ScottCO-CEO of Sub Advisor
PMPEXPrimark Meketa Private Equity Investments Fund
Open-market purchase
BUY$150K
8,601 sh
Sep 28, 2026Sep 30, 2026
traded Sep 28, 2026
+2dSEC Form 4

Evidence

47
KR
Kamfar RaminDirector
BPREBluerock Private Real Estate Fund
Open-market purchase
BUY$1.94M
154.1K sh
Sep 30, 2026Sep 30, 2026
traded Sep 30, 2026
+0dSEC Form 4

Evidence

47
KR
Kamfar RaminDirector
BPREBluerock Private Real Estate Fund
Open-market purchase
BUY$1.71M
135.8K sh
Sep 29, 2026Sep 30, 2026
traded Sep 29, 2026
+1dSEC Form 4

Evidence

44
BJ
Bistricer JacobChief Operating Officer
CLPRClipper Realty Inc.
Open-market purchase
BUY$246K
73.5K sh
Sep 28, 2026Sep 30, 2026
traded Sep 28, 2026
+2dSEC Form 4

Evidence

44
MD
Mallick DhirajChief Operating Officer
CBRSCerebras Systems Inc.
Open-market sale · 10b5-1 plan
SELL$13.42M
68.8K sh
Sep 29, 2026Sep 30, 2026
traded Sep 29, 2026
+1dSEC Form 4

Evidence

42
DM
Doehner Cobian MauricioEVP Corporate Affairs
CXCEMEX SAB DE CV
Open-market sale
SELL$8.88M
927.9K sh
Sep 30, 2026Sep 30, 2026
traded Sep 30, 2026
+0dSEC Form 4

Evidence

42
RB
Ruddy Jordan B.President
BPREBluerock Private Real Estate Fund
Open-market purchase
BUY$30K
2,400 sh
Sep 28, 2026Sep 30, 2026
traded Sep 28, 2026
+2dSEC Form 4

Evidence

41
KP
Komin Robert Patrick Jr.Chief Financial Officer
CBRSCerebras Systems Inc.
Open-market sale · 10b5-1 plan
SELL$2.25M
11.2K sh
Sep 29, 2026Sep 30, 2026
traded Sep 29, 2026
+1dSEC Form 4

Evidence

41
FA
Friedman Joel AlbertExec VP, CAO & Treasurer
BFSSAUL CENTERS, INC.
Open-market purchase
BUY$3,706
200 sh
Sep 28, 2026Sep 30, 2026
traded Sep 28, 2026
+2dSEC Form 4

Evidence

41
DP
Davy Joseph P.Director, Chief Executive Officer, 10% Owner
PARABanzai International, Inc.
Open-market purchase
BUY—
116.0K sh
Sep 28, 2026Sep 30, 2026
traded Sep 28, 2026
+2dSEC Form 4

Evidence

41
OP
O'Heeron PeteDirector, COB, Secretary, Treasurer, 10% Owner
LBSRLIBERTY STAR URANIUM & METALS CORP.
Open-market purchase
BUY$3,910
171.5K sh
Sep 28, 2026Sep 30, 2026
traded Sep 28, 2026
+2dSEC Form 4

Evidence

41
OP
O'Heeron PeteDirector, COB, Secretary, Treasurer, 10% Owner
LBSRLIBERTY STAR URANIUM & METALS CORP.
Open-market purchase
BUY$1,955
85.7K sh
Sep 28, 2026Sep 30, 2026
traded Sep 28, 2026
+2dSEC Form 4

Evidence

39
PT
Plott Ronald ToddDirector
PHIOPhio Pharmaceuticals Corp.
Open-market purchase
BUY$5,200
5,000 sh
Sep 29, 2026Sep 30, 2026
traded Sep 29, 2026
+1dSEC Form 4

Evidence

39
PT
Plott Ronald ToddDirector
PHIOPhio Pharmaceuticals Corp.
Open-market purchase
BUY$5,150
5,000 sh
Sep 28, 2026Sep 30, 2026
traded Sep 28, 2026
+2dSEC Form 4

Evidence

38
KP
Komin Robert Patrick Jr.Chief Financial Officer
CBRSCerebras Systems Inc.
Open-market sale · 10b5-1 plan
SELL$585K
3,000 sh
Sep 29, 2026Sep 30, 2026
traded Sep 29, 2026
+1dSEC Form 4

Evidence

37
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Open-market purchase
BUY$179K
6,739 sh
Sep 29, 2026Sep 30, 2026
traded Sep 29, 2026
+1dSEC Form 4

Evidence

37
MD
Mallick DhirajChief Operating Officer
CBRSCerebras Systems Inc.
Open-market sale · 10b5-1 plan
SELL$3.66M
18.7K sh
Sep 29, 2026Sep 30, 2026
traded Sep 29, 2026
+1dSEC Form 4

Evidence

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K